Thyroid Eye Disease Market By Diagnosis (Ultrasound, Imaging Tests, Radioactive Iodine Uptake & Blood Sample), By Treatment (Anti-Thyroid Medication, Radioactive Thyroid Therapy, and Surgery), By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2016-26
Published:
March 2020
Report Code:
BWC19439
Available Format:
PDF PDF Icon
Pages:
180

thyroid eye disease market bwc19439

COVID-19

We've been tracking the direct impact of COVID-19 on this market, and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Contact our sales team for more details at

Contact Now

Global Thyroid Eye Disease Market Forecast and Trends

The global Thyroid Eye Disease market has reached USD 182 Million in 2019 and estimated to reach USD 318 Million in 2026 and anticipated to grow by CAGR of 8.53% during the forecast period 2020- 2026. The global market for thyroid eye disease has grown significantly due to various factors consisting of rising thyroid disorder prevalence, which is the explanation for a higher pool of patients suffering from thyroid eye disease or Graves ' disease. Technological advancement in the market for thyroid eye disease has led to developments and the launch of various treatments such as radioactive iodine and thionamides that contribute to the segment's emerging growth.

The availability of generic pharmaceutical products and favorable reimbursement policies also drive market growth. The major drivers of the demand for thyroid eye disease are increased numbers of patients with thyroid disorders, favorable reimbursement rates for treatment, and increased awareness of the complications associated with thyroid disorders. Increasing iodine deficiency and screening for thyroid tumors is one of the leading factors driving global market growth over the 2020-2026 forecast period.

Global Thyroid Eye Disease Market: Overview

Thyroid eye disease, commonly referred to as Graves ' disease, is a condition of the immune system that results in hyperthyroidism. It is a problem that causes the overproduction of thyroid hormones by the thyroid gland. Thyroid eye disease is a type of inflammation of the muscles of the skin, eyelids, tear glands, and fatty tissues behind the eyes. This may cause the eyes and eyelids to turn red, swollen and painful, and may move the eyes forward.

In some cases, the muscles that drive the eyes become swollen and stiff so that they no longer move in line with each other; this can cause double vision. Rarely thyroid eye disease can cause decreased vision in the back of the eye due to pressure on the nerve or ulcers developing on the front of the eyes if the eyelids can not close completely. Thyroid eye disease is an autoimmune condition, also known as Graves ' Orbitopathy or Ophthalmopathy. This occurs when the immune system of the body attacks the tissue around the eye and causes inflammation in the muscles around and behind the eye. The same autoimmune disorder that causes thyroid eye disease also affects the thyroid gland in most cases, leading to Graves ' disease. The illness of Graves most commonly causes overactivity of the thyroid (hyperthyroidism), but may also rarely cause under activity of the thyroid (hypothyroidism). Thyroid eye disease can occur in people with overactive, underactive, or normal functioning thyroid.

Growth Drivers

Increasing awareness coupled with deteriorating lifestyle

Growing awareness around the globe, declining lifestyle due to alcohol and smoking use, and increasing thyroid tumors create the opportunity for the future and will further fuel market growth. Increasing iodine deficiency and screening of thyroid tumors also drive as key factors for the market growth of the thyroid eye disease market with a significant growth rate.

Technological Advancement

Substantial technological improvements have been made in the system and in the development of new technologies that have enabled ultrasound to become more widely adopted globally for soft tissue diagnosis. Technological equipment development involves a decrease in machine size, less heat generation, and more energy efficiency. All these changes in the hardware, together with significant improvements in image quality, help to diagnose thyroid eye disease effectively.

Restraint

High Cost & low availability of skilled professional

Various factors are acting as the barriers for this market, which includes lack of experienced professional’s availability in developing economies and high costs associated with thyroid eye disease medication and treatment are a key factor that can hinder the rate of growth in the global thyroid eye disease market.

Global Thyroid Eye Disease Market: Diagnosis

The market can be bifurcated as an ultrasonic, MRI test, Radioactive Iodine Uptake, and blood sample depending on the diagnosis. The primary diagnostic technique adopted globally is among the ultrasound groups. The most common cause of proptosis in adults is thyroid-associated orbitopathy (or thyroid-associated ophthalmopathy) and is most frequently associated with thyroid eye disease. On imaging, the extraocular muscle bellies are characterized by bilateral and symmetrical enlargement.

Global Thyroid Eye Disease Market: Treatment

The market is diversified based on diagnosis as anti-thyroid medications, radioactive iodine therapy, and surgery. Anti-thyroid medicine is expected to hold the largest share among the treatment because of its property of being the least non-invasive drug. That slows the thyroid function and inhibits thyroid hormone production. Propylthiouracil (PTU) and methimazole (MMI) are inexpensive, without side effects, and are the most frequently used treatment option for this disease. Diagnosis for the thyroid-eye disease requires two stages. The first phase of diagnosis includes the treatment of severe eye disease, which lasts for 2-3 years. The determination of thyroid eye disorders in the active phase focuses on maintaining the sight and the integrity of the cornea, as well as combating double vision.


Global Thyroid Eye Disease Market: Regional Insights

Global Thyroid Eye Disease market segmented into five regions, including North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the market with its advanced technology capability that provides various treatment options, and high spending on health care. Europe has a significant market share cover due to the presence of growth opportunities. The Asia Pacific is regarded as the fastest growing market segment thanks to rapidly developing technologies, increased awareness among people, and increased prevalence of thyroid eye disease.


Thyroid Eye Disease: Competitive Landscape

Thyroid Eye Disease market is fragmented owing to the presence of number of large-sized companies that hold the majority share of Thyroid Eye Disease market are AbbVie Inc., Abbott Laboratories Inc., Allergan Plc, Apitope Technology Ltd., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly And Company, Epivax Inc., GlaxoSmithKline Plc, Johnson & Johnson, Macleods Pharmaceuticals Ltd., Merck & Co. Inc., Mylan N.V, Novartis International Ag, Pfizer Inc., and Other Prominent Players.

The objective of the Study:

To analyze and forecast the global market size of Thyroid Eye Disease.

Analyzing careful market segmentation and estimating value-based market size through region-based segmentation.

The global Thyroid Eye Disease is divided into five regions: North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

To outline, categorize, and forecast the global AI in the agricultural market based on diagnosis and treatment coupled with the region.

To examine competitive developments in the global thyroid eye disease market, such as technological advancement, services, and regulatory framework.

To emphasize the impact study of market dynamics variables such as users, constraints, opportunities, and challenges.

Profiling key players strategically and analyzing their market shares comprehensively, together with detailing the competitive environment for market leaders.

Scope of the Report:

Attribute

Details

Years Considered

Historical data – 2016-2019

Base Year – 2019

Forecast – 2020 – 2026

Facts Covered

Revenue in USD Million/Billion

Market Coverage

U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Mexico, Argentina, Japan, South Korea, China, India, UAE, South Africa, Saudi Arabia

Product/Service Segmentation

By Diagnosis and Treatment

Key Players

Abbvie Inc., Abbott Laboratories Inc., Allergan Plc, Apitope Technology Ltd., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly And Company, Epivax, Inc, GlaxoSmithKline Plc, Johnson & Johnson, Macleods Pharmaceuticals Ltd., Merck & Co., Inc, Mylan NV, Novartis International Ag, Pfizer Inc., and Other Prominent Players

By Diagnosis

·         Ultrasound

·         Imaging Tests

·         Radioactive Iodine Uptake

·         Blood Sample

By Treatment

·         Anti- Thyroid Medication

·         Radioactive Iodine Therapy

·         Surgery

By Region: 

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East & Africa

Business Questions Answer by the Report

How will the market drivers, restraints, and opportunities affect the market dynamics?

What will be the market size in terms of value and volume and market statistics with a detailed classification?

Which segment dominates the market or region, and one will be the fastest-growing, and why?

A comprehensive survey of the competitive landscape and the market participant players

Analysis of strategy adopted by the key player and their impact on other players.

Customization Scope for the Client

Client satisfaction is our first and last priority, and that’s why BlueWeave Consulting offers customization according to Company’s specific needs. The following customization options are available for the report:

Additional Company Information

With five additional company detail analysis

Additional country analysis

Detailed segment analysis

Why Choose us

  • 24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Coustom Research Service

    Ask the Analyst to customize an exclusive study to serve your research needs.

  • Quality & Accuracy

    offers best quality reports based on various authentic and accurate data findings.

  • Data Visualization

    As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization

  • Information security

    We never share your personal and confidential information. Your personal information is safe and secure with us.